TrialPharmacology, biochemistry, and behavior2008

The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers.

R De La Garza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.